At the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/OD), during the 'Abeta Targeting Therapies in AD' symposium on 3 April, Roche presented interim trial ...

that a buildup of amyloid beta in the brain is the root cause of the disease. Known as the amyloid hypothesis, this theory emerged in the 1980s after researchers identified amyloid plaques as a ...

Credit: Lightspring / Shutterstock. At the AD/PD 2025 International Conference on Alzheimer’s and Parkinson’s Diseases (AD/OD), during the ‘Abeta Targeting Therapies in AD’ symposium on 3 April, Roche ...

That view is informed by data on the first wave of successful anti-amyloid-beta antibodies. Roche is hoping to improve on those molecules by pairing its antibody with technology for crossing the ...

Labcorp's pTau-217/Beta Amyloid 42 Ratio blood test meets the performance criteria to confirm amyloid pathology consistent with Alzheimer's disease BURLINGTON, N.C., April 2, 2025 /PRNewswire ...

This important study shows, for the first time, the structure and snapshots of the dynamics of the full-length soluble Angiotensin-I converting enzyme dimer. The combination of structural and ...

Beta-blockers can treat a variety of conditions including diabetes. They might cause certain side effects such as headaches and fatigue. People with diabetes tend to develop heart disease or ...

Randall Bateman, MD, Charles F and Joanne Knight Distinguished Professor of Neurology at WashU Medicine. A study of Roche's anti-amyloid drug gantenerumab has suggested that early treatment to ...

And Apple just released the first beta for the next update, iOS 18.5, to developers. The first developer beta has so far been found to offer two main changes that are intended to make using ...

Despite missing this important feature—promised at WWDC last fall—there are lots of improvements in iOS 18.4. The iOS 18.4 beta began on February 21 with a developer beta, and the first public ...